FR2353519A1
(fr)
*
|
1975-12-08 |
1977-12-30 |
Roussel Uclaf |
Nouveaux derives de l'aminobenzocycloheptene et leurs sels, procede de preparation et application a titre de medicaments desdits produits
|
DE2931399A1
(de)
*
|
1979-08-02 |
1981-02-26 |
Kali Chemie Pharma Gmbh |
Neue 3-amino-1-benzoxepin-derivate und ihre salze, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
|
DE2931398A1
(de)
*
|
1979-08-02 |
1981-02-26 |
Kali Chemie Pharma Gmbh |
Neue 1-benzoxepin-5(2h)-on-derivate und ihre salze, verfahren und zwischenprodukte zu deren herstellung und diese verbindungen enthaltende arzneimittel
|
PH22343A
(en)
*
|
1983-02-15 |
1988-08-12 |
Merrell Dow Pharma |
2h-(1) benzoxepino (5,4-b) 1,4-oxazine derivatives
|
NZ207111A
(en)
*
|
1983-02-15 |
1986-07-11 |
Merrell Dow Pharma |
(4a,11b)-3,4,4a,5,6,11b-hexahydro-2h-(1)benzoxepino(5,4-b)-1,4 oxazine derivatives and pharmaceutical compositions
|
DE3440296A1
(de)
*
|
1984-11-05 |
1986-05-15 |
Kali-Chemie Pharma Gmbh, 3000 Hannover |
3-amino-2,3-dihydro-1-benzoxepin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
US4975461A
(en)
*
|
1986-06-19 |
1990-12-04 |
E. R. Squibb & Sons, Inc. |
P-aminophenols, derivatives thereof and method of use
|
AU597671B2
(en)
*
|
1986-06-20 |
1990-06-07 |
Suntory Limited |
2-Phenylbenzoxepin derivative
|
FR2698873B1
(fr)
*
|
1992-12-07 |
1995-02-24 |
Lipha |
Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant.
|
US6268392B1
(en)
|
1994-09-13 |
2001-07-31 |
G. D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
|
US6262277B1
(en)
|
1994-09-13 |
2001-07-17 |
G.D. Searle And Company |
Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
US6107494A
(en)
*
|
1994-09-13 |
2000-08-22 |
G.D. Searle And Company |
Substituted 5-aryl-benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
US6642268B2
(en)
|
1994-09-13 |
2003-11-04 |
G.D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
|
EP0781278B1
(en)
*
|
1994-09-13 |
2001-03-14 |
Monsanto Company |
Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
US5994391A
(en)
*
|
1994-09-13 |
1999-11-30 |
G.D. Searle And Company |
Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
EP1440972A1
(en)
*
|
1996-03-11 |
2004-07-28 |
G.D. Searle & Co. |
Novel benzothiepines having pharmaceutical activity.
|
HUP9903047A3
(en)
*
|
1996-03-11 |
2002-12-28 |
G D Searle & Co Chicago |
Novel benzothiazepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
AU723123B2
(en)
*
|
1996-03-11 |
2000-08-17 |
G.D. Searle & Co. |
Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
US6221897B1
(en)
|
1998-06-10 |
2001-04-24 |
Aventis Pharma Deutschland Gmbh |
Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
|
WO2000038723A1
(en)
|
1998-12-23 |
2000-07-06 |
G.D. Searle Llc |
Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
|
DE69908414T2
(de)
|
1998-12-23 |
2004-04-01 |
G.D. Searle Llc, Chicago |
Kombinationen von ileumgallensäuretransports inhibitoren und cholesteryl ester transfer protein inhibitoren
|
WO2000038722A1
(en)
|
1998-12-23 |
2000-07-06 |
G.D. Searle & Co. |
COMBINATIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG CoA REDUCTASE INHIBITORS FOR CARDIOVASCULAR INDICATIONS
|
MXPA01006470A
(es)
|
1998-12-23 |
2003-06-06 |
Searle Llc |
Combinaciones de inhibidores de transporte de acido biliar ileal y agentes de secuentro de acido biliar para indicaciones cardiovasculares.
|
EP1140184B1
(en)
|
1998-12-23 |
2003-06-04 |
G.D. Searle LLC. |
Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
|
DK1140186T3
(da)
|
1998-12-23 |
2003-09-29 |
Searle Llc |
Kombinationer af cholesterylestertransferproteinhæmmere og derivater af fibrinsyre til hjertekar indikationer
|
AU776658B2
(en)
|
1998-12-23 |
2004-09-16 |
G.D. Searle Llc |
Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
|
AU2001240115A1
(en)
|
2000-03-10 |
2001-09-24 |
Pharmacia Corporation |
Method for the preparation of tetrahydrobenzothiepines
|
EP1448546A4
(en)
|
2001-11-02 |
2005-02-02 |
Searle Llc |
MONO- AND DI-FLUORINATED BENZOTHIEPINE COMPOUNDS AS INHIBITORS OF TRANSPORT OF ACIDICALLY DEPENDENT SODIUM ACILIC (ASBT) BILIARY ACIDS AND TAUROCHOLATE RECOVERY
|
AU2003207431A1
(en)
|
2002-01-17 |
2003-09-02 |
Pharmacia Corporation |
Novel alkyl/aryl hydroxy or keto thiepines.
|
DK2771003T3
(en)
|
2011-10-28 |
2017-07-17 |
Lumena Pharmaceuticals Llc |
Bile acid recycling inhibitors for the treatment of pediatric cholestatic liver disease
|
JP6217939B2
(ja)
|
2011-10-28 |
2017-10-25 |
ルメナ ファーマシューティカルズ エルエルシー |
高胆汁血症および胆汁うっ滞性肝疾患の処置のための胆汁酸再利用阻害剤
|